■已经设计了许多智能手机应用程序进行诊断,治疗,和眼科症状管理。尽管对目的进行系统评估很重要,目标疾病,有效性,以及智能手机应用程序对其有效利用的效用,很少有研究正式评估它们的有效性,可靠性,和临床效用。
■本报告确定了具有眼科临床应用潜力的智能手机应用,并总结了其实用性的证据。
■我们在2022年7月28日搜索了PubMed和EMBASE,以获取报告有关治疗有效性的原始数据的文章,疾病检测,诊断准确性,疾病监测,以及1987年1月1日至2022年7月25日发布的智能手机应用在眼科中的可用性。使用JoannaBriggs研究所关键评估清单评估了它们的质量。
■最初的搜索产生了510篇文章。在根据纳入和排除标准删除115个重复项和285个文章后,对其余110篇文章的全文进行了审查。此外,最终的定性综合包括71篇文章。所有研究均被确定为高(87.3%)或中等(12.7%)质量。就各自感兴趣的应用而言,24项(33.8%)研究评估了诊断准确性,17人(23.9%)评估了疾病检测,3(4.2%)评估了干预效果。共识别出48个智能手机应用,其中27(56.3%)是公开的。17项(35.4%)申请包括眼科检查功能,13(27.1%)包括旨在疾病检测的功能,10人(20.8%)包括支持医务人员的职能,五项(10.4%)包括与疾病教育有关的功能,3项(6.3%)包括提高患者治疗依从性的功能.针对弱视的应用数量最多(18.8%),其次是视网膜疾病(10.4%)。两个(4.2%)智能手机应用程序报告了治疗疾病的显着疗效。
■在这篇系统综述中,对与诊断准确性相关的研究进行了全面评估,疾病可检测性,以及智能手机在眼科应用中的功效。确定了具有潜在临床效用的48个应用。适当的智能手机应用程序有望通过远程医疗早期发现未诊断的疾病,并通过远程监控慢性疾病来预防视觉功能障碍。
■专有或商业披露可以在参考文献之后找到。
UNASSIGNED: Numerous smartphone applications have been devised for diagnosis, treatment, and symptom management in ophthalmology. Despite the importance of systematic evaluation of the purpose, target disease, effectiveness, and utility of smartphone applications to their effective utilization, few studies have formally evaluated their validity, reliability, and clinical utility.
UNASSIGNED: This report identifies smartphone applications with potential for clinical implementation in ophthalmology and summarizes the evidence on their practical utility.
UNASSIGNED: We searched PubMed and EMBASE on July 28, 2022, for articles reporting original data on the effectiveness of treatment, disease detection, diagnostic accuracy, disease monitoring, and usability of smartphone applications in ophthalmology published between January 1, 1987, and July 25, 2022. Their quality was assessed using the Joanna Briggs Institute Critical Appraisal Checklist.
UNASSIGNED: The initial search yielded 510 articles. After removing 115 duplicates and 285 articles based on inclusion and exclusion criteria, the full texts of the remaining 110 articles were reviewed. Furthermore, 71 articles were included in the final qualitative synthesis. All studies were determined to be of high (87.3%) or moderate (12.7%) quality. In terms of respective application of interest, 24 (33.8%) studies assessed diagnostic accuracy, 17 (23.9%) assessed disease detection, and 3 (4.2%) assessed intervention efficacy. A total of 48 smartphone applications were identified, of which 27 (56.3%) were publicly available. Seventeen (35.4%) applications included functions for ophthalmic examinations, 13 (27.1%) included functions aimed at disease detection, 10 (20.8%) included functions to support medical personnel, five (10.4%) included functions related to disease education, and three (6.3%) included functions to promote treatment adherence for patients. The largest number of applications targeted amblyopia (18.8%), followed by retinal disease (10.4%). Two (4.2%) smartphone applications reported significant efficacy in treating diseases.
UNASSIGNED: In this systematic
review, a comprehensive appraisal is presented on studies related to diagnostic accuracy, disease detectability, and efficacy of smartphone applications in ophthalmology. Forty-eight applications with potential clinical utility are identified. Appropriate smartphone applications are expected to enable early detection of undiagnosed diseases via telemedicine and prevent visual dysfunction via remote monitoring of chronic diseases.
UNASSIGNED: Proprietary or commercial disclosure may be found after the references.